Articles with public access mandates - Martens ACLearn more
Not available anywhere: 1
An atlas of bloodstream-accessible bone marrow proteins for site-directed therapy of acute myeloid leukemia
L Angenendt, S Reuter, D Kentrup, AS Benk, F Neumann, J Hüve, ...
Leukemia 32 (2), 510-519, 2018
Mandates: German Research Foundation
Available somewhere: 22
Dll1+ secretory progenitor cells revert to stem cells upon crypt damage
JH Van Es, T Sato, M Van De Wetering, A Lyubimova, AN Yee Nee, ...
Nature cell biology 14 (10), 1099-1104, 2012
Mandates: US National Institutes of Health
Peyer's patch M cells derived from Lgr5+ stem cells require SpiB and are induced by RankL in cultured “miniguts”
W de Lau, P Kujala, K Schneeberger, S Middendorp, VSW Li, N Barker, ...
Molecular and cellular biology, 2012
Mandates: Royal Netherlands Academy of Arts and Sciences
Non-canonical PRC1. 1 targets active genes independent of H3K27me3 and is essential for leukemogenesis
V van den Boom, H Maat, M Geugien, AR López, AM Sotoca, J Jaques, ...
Cell reports 14 (2), 332-346, 2016
Mandates: Netherlands Organisation for Scientific Research, European Commission, Dutch …
Prospective isolation of mesenchymal stem cells from multiple mammalian species using cross-reacting anti-human monoclonal antibodies
H Rozemuller, HJ Prins, B Naaijkens, J Staal, HJ Bühring, AC Martens
Stem cells and development 19 (12), 1911-1921, 2010
Mandates: German Research Foundation
Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation
WA Noort, M Oerlemans, H Rozemuller, D Feyen, S Jaksani, D Stecher, ...
Journal of Cellular and Molecular Medicine 16 (8), 1827-1839, 2012
Mandates: German Research Foundation
Establishing human leukemia xenograft mouse models by implanting human bone marrow–like scaffold-based niches
A Antonelli, WA Noort, J Jaques, B de Boer, R de Jong-Korlaar, ...
Blood, The Journal of the American Society of Hematology 128 (25), 2949-2959, 2016
Mandates: European Commission, Dutch Cancer Society
Preclinical activity of the oral proteasome inhibitor MLN9708 in Myeloma bone disease
A Garcia-Gomez, D Quwaider, M Canavese, EM Ocio, Z Tian, JF Blanco, ...
Clinical cancer research 20 (6), 1542-1554, 2014
Mandates: Government of Spain
Accessory cells of the microenvironment protect multiple myeloma from T-cell cytotoxicity through cell adhesion-mediated immune resistance
SJ de Haart, NWCJ van de Donk, MC Minnema, JH Huang, ...
Clinical cancer research 19 (20), 5591-5601, 2013
Mandates: US National Institutes of Health, Dutch Cancer Society
N-cadherin-mediated interaction with multiple myeloma cells inhibits osteoblast differentiation
RWJ Groen, MFM de Rooij, KA Kocemba, RM Reijmers, ...
Haematologica 96 (11), 1653, 2011
Mandates: US National Institutes of Health
PHF19 promotes multiple myeloma tumorigenicity through PRC2 activation and broad H3K27me3 domain formation
Z Ren, JH Ahn, H Liu, YH Tsai, NV Bhanu, B Koss, DF Allison, A Ma, ...
Blood, The Journal of the American Society of Hematology 134 (14), 1176-1189, 2019
Mandates: US Department of Defense, US National Institutes of Health
Effects of MSC coadministration and route of delivery on cord blood hematopoietic stem cell engraftment
S Carrancio, C Romo, T Ramos, N Lopez-Holgado, S Muntion, HJ Prins, ...
Cell transplantation 22 (7), 1171-1183, 2013
Mandates: Government of Spain
Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A
S Sarkar, M van Gelder, W Noort, Y Xu, KMA Rouschop, R Groen, ...
Cancer Immunology, Immunotherapy 64, 951-963, 2015
Mandates: US National Institutes of Health, Dutch Cancer Society
Modeling BCR-ABL and MLL-AF9 leukemia in a human bone marrow-like scaffold-based xenograft model
P Sontakke, M Carretta, J Jaques, AZ Brouwers-Vos, L Lubbers-Aalders, ...
Leukemia 30 (10), 2064-2073, 2016
Mandates: European Commission, Dutch Cancer Society
Sepantronium bromide (YM155) improves daratumumab-mediated cellular lysis of multiple myeloma cells by abrogation of bone marrow stromal cell-induced resistance
SJ de Haart, L Holthof, WA Noort, MC Minnema, ME Emmelot, ...
Haematologica 101 (8), e339, 2016
Mandates: Worldwide Cancer Research, UK, Dutch Cancer Society
Liposomal dexamethasone inhibits tumor growth in an advanced human-mouse hybrid model of multiple myeloma
AK Deshantri, MH Fens, RWJ Ruiter, JM Metselaar, G Storm, L van Bloois, ...
Journal of controlled release 296, 232-240, 2019
Mandates: Netherlands Organisation for Scientific Research
Correlation of high-resolution X-ray micro-computed tomography with bioluminescence imaging of multiple myeloma growth in a xenograft mouse model
AA Postnov, H Rozemuller, V Verwey, H Lokhorst, N De Clerck, ...
Calcified tissue international 85, 434-443, 2009
Mandates: Research Foundation (Flanders)
Brief report: autologous stem cell transplantation restores immune tolerance in experimental arthritis by renewal and modulation of the teff cell compartment
EM Delemarre, STA Roord, T van den Broek, E Zonneveld‐Huijssoon, ...
Arthritis & Rheumatology 66 (2), 350-356, 2014
Mandates: US National Institutes of Health
Deazaneplanocin a is a promising drug to kill multiple myeloma cells in their niche
J Gaudichon, F Milano, J Cahu, L DaCosta, AC Martens, JM Renoir, ...
PloS one 9 (9), e107009, 2014
Mandates: Swiss Cancer League
Bone morphogenetic protein 4 gene therapy in mice inhibits myeloma tumor growth, but has a negative impact on bone
M Westhrin, T Holien, M Zahoor, SH Moen, G Buene, B Størdal, H Hella, ...
Journal of Bone and Mineral Research Plus 4 (1), e10247, 2020
Mandates: Research Council of Norway, Government of Spain
Publication and funding information is determined automatically by a computer program